Neurodegenerative Disease and COVID-19: Assessing Outcomes in Hospitalized Patients
A team of researchers assessed COVID-19 outcomes in patients with neurodegenerative diseases compared with patients without such disease.
A team of researchers assessed COVID-19 outcomes in patients with neurodegenerative diseases compared with patients without such disease.
A team of investigators sought to determine whether κ- and λ-FLC index may predict early multiple sclerosis disease activity independent of demographics, clinical, and MRI characteristics.